ROSSOTTI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.500
AS - Asia 1.460
EU - Europa 1.434
SA - Sud America 149
Continente sconosciuto - Info sul continente non disponibili 140
AF - Africa 44
OC - Oceania 6
Totale 4.733
Nazione #
US - Stati Uniti d'America 1.403
IT - Italia 559
SG - Singapore 369
CN - Cina 345
VN - Vietnam 287
DE - Germania 258
GB - Regno Unito 182
BD - Bangladesh 177
BR - Brasile 115
HK - Hong Kong 115
RU - Federazione Russa 82
SE - Svezia 80
CA - Canada 68
FR - Francia 52
IN - India 50
NL - Olanda 43
ES - Italia 33
FI - Finlandia 30
IE - Irlanda 28
TR - Turchia 22
CI - Costa d'Avorio 17
KR - Corea 17
MX - Messico 15
JP - Giappone 14
PL - Polonia 13
IQ - Iraq 12
CH - Svizzera 11
ID - Indonesia 10
UA - Ucraina 10
PH - Filippine 9
AT - Austria 8
CO - Colombia 8
DK - Danimarca 8
AR - Argentina 7
BE - Belgio 7
AU - Australia 6
MK - Macedonia 5
RO - Romania 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
CL - Cile 4
TW - Taiwan 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
PY - Paraguay 3
SC - Seychelles 3
SI - Slovenia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
EU - Europa 2
GA - Gabon 2
GP - Guadalupe 2
JM - Giamaica 2
LK - Sri Lanka 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CM - Camerun 1
CY - Cipro 1
EG - Egitto 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
MY - Malesia 1
PA - Panama 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 4.596
Città #
Singapore 217
Ashburn 203
Frankfurt am Main 177
Southend 134
Dallas 131
Milan 124
Chandler 104
San Jose 98
Hong Kong 95
Ho Chi Minh City 82
Rome 67
New York 62
Hanoi 61
Beijing 57
Santa Clara 57
Council Bluffs 56
Los Angeles 45
Toronto 34
Da Nang 30
Hefei 30
Hanover 29
Dublin 28
Princeton 26
Buffalo 22
Boardman 21
Bologna 19
Lauterbourg 19
Moscow 18
Naples 18
Redwood City 18
Abidjan 17
Houston 17
Seattle 17
São Paulo 17
Wilmington 17
Phoenix 14
Bengaluru 13
Haiphong 13
Helsinki 13
Chicago 11
Munich 11
Tokyo 11
Warsaw 11
Atlanta 10
Cangzhou 10
Denver 10
Grafing 10
Istanbul 10
London 10
Seoul 10
Shanghai 10
Cambridge 9
Des Moines 9
Jakarta 9
Jinan 9
Palermo 8
The Dalles 8
Turku 8
Washington 8
Ancona 7
Ann Arbor 7
Brooklyn 7
City of London 7
Hillsboro 7
Thái Nguyên 7
Woodbridge 7
Baghdad 6
Barcelona 6
Bắc Ninh 6
Changsha 6
Elk Grove Village 6
Fairfield 6
Lappeenranta 6
Magenta 6
Mumbai 6
Shenzhen 6
Wuhan 6
Amsterdam 5
Berlin 5
Chennai 5
Columbus 5
Dearborn 5
Fuzhou 5
Guangzhou 5
Jacksonville 5
Jerez de la Frontera 5
Nuremberg 5
Paris 5
Reston 5
Salerno 5
Skopje 5
Bibbiano 4
Biên Hòa 4
Can Tho 4
Carlentini 4
Dong Ket 4
Fremont 4
Genoa 4
Gualdo Cattaneo 4
Hangzhou 4
Totale 2.633
Nome #
Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients 501
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 299
Outbreak of Acute Hepatitis A involving young men in Lombardy region, Italy: Risk factors, clinical and virological characteristics 279
The impact of HIV infection and men who have sex with men status on hepatitis A infection: The experience of two tertiary centres in Northern Italy during the 2017 outbreak and in the 2009-2016 period 268
Determinants of worse liver‐related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 258
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 232
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 230
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 229
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 213
Outbreak of acute hepatitis A involving young men in Lombardy Region, Italy: risk factors, clinical and virological characteristics 207
Efficacy and resistance of recently developed non-nucleoside reverse transcriptase inhibitors for HIV-1 201
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohort 196
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 171
Unconventional use of injectable long-acting cabotegravir and rilpivirine against HIV-1 in PWH in clinical need: 52 weeks real-world data 162
Preliminary observations on IGRA testing for TB infection in patients with severe COVID-19 eligible for immunosuppressive therapy 151
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 145
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 144
Rilpivirine resistance and the dangerous liaisons with substitutions at position 184 among patients infected with HIV-1: analysis from a national drug-resistance database (ARCA) 144
HIV infection among adolescents and young adults in Italy: epidemiology, viro-immunological and treatment outcomes 132
The use of intrahepatic portosystemic shunt in HIV positive patients : A retrospective multicentric study 120
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 104
Outbreak of Vancomycin-Resistant Enterococcus in a NICU: Insights into Molecular Detection and Infection Control 98
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 87
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 68
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection 60
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort 34
Totale 4.733
Categoria #
all - tutte 12.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.098


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022233 0 0 16 12 16 3 28 34 46 27 8 43
2022/2023293 41 40 20 22 31 44 2 19 44 6 20 4
2023/2024292 1 13 12 10 47 18 32 23 21 26 46 43
2024/2025687 42 72 36 86 30 28 35 44 54 76 65 119
2025/20262.312 148 158 213 195 128 124 375 116 211 194 242 208
2026/2027352 209 127 16 0 0 0 0 0 0 0 0 0
Totale 4.733